These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 35810311

  • 1. An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.
    Richards D, Millns H, Cookson L, Lukas MA.
    Orphanet J Rare Dis; 2022 Jul 09; 17(1):259. PubMed ID: 35810311
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis.
    Richards DB, Cookson LM, Barton SV, Liefaard L, Lane T, Hutt DF, Ritter JM, Fontana M, Moon JC, Gillmore JD, Wechalekar A, Hawkins PN, Pepys MB.
    Sci Transl Med; 2018 Jan 03; 10(422):. PubMed ID: 29298867
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.
    Pepys MB.
    Front Immunol; 2018 Jan 03; 9():2382. PubMed ID: 30459761
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Intravenous Dose of Miridesap in Healthy Japanese Subjects.
    Ino H, Doi Y, Liefaard L, Cookson L, Chen C, Itoh H, Igarashi H, Nakano A.
    Clin Pharmacol Drug Dev; 2019 Jul 03; 8(5):612-618. PubMed ID: 30556959
    [Abstract] [Full Text] [Related]

  • 7. Randomized phase I trial HIV-CORE 003: Depletion of serum amyloid P component and immunogenicity of DNA vaccination against HIV-1.
    Borthwick NJ, Lane T, Moyo N, Crook A, Shim JM, Baines I, Wee EG, Hawkins PN, Gillmore JD, Hanke T, Pepys MB.
    PLoS One; 2018 Jul 03; 13(5):e0197299. PubMed ID: 29772028
    [Abstract] [Full Text] [Related]

  • 8. Novel methods to determine complement activation in human serum induced by the complex of Dezamizumab and serum amyloid P.
    Ma J, Liu Q, White JR.
    J Biol Chem; 2021 Oct 03; 297(4):101136. PubMed ID: 34461096
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis.
    Gillmore JD, Tennent GA, Hutchinson WL, Gallimore JR, Lachmann HJ, Goodman HJ, Offer M, Millar DJ, Petrie A, Hawkins PN, Pepys MB.
    Br J Haematol; 2010 Mar 03; 148(5):760-7. PubMed ID: 20064157
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.
    Hawkins PN, Richardson S, Vigushin DM, David J, Kelsey CR, Gray RE, Hall MA, Woo P, Lavender JP, Pepys MB.
    Arthritis Rheum; 1993 Jun 03; 36(6):842-51. PubMed ID: 8507227
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.